Clinical Biotechnologists apply advanced biotechnological methods and techniques in a healthcare setting to diagnose, treat, and prevent diseases. They work with biological samples like blood, tissues, and fluids to develop diagnostic tools that identify pathogens, genetic disorders, and biomarkers associated with various diseases. By utilizing cutting-edge technologies such as PCR (Polymerase Chain Reaction), gene sequencing, and biomarker detection, clinical biotechnologists contribute to early disease detection, accurate diagnosis, and personalized treatment plans. They are essential in advancing the field of molecular diagnostics, enabling healthcare professionals to make informed decisions based on a patient’s genetic and molecular profile.
Clinical biotechnologists also play a vital role in the development of therapies, particularly in the realm of gene therapy, stem cell treatments, and regenerative medicine. They collaborate with medical professionals to translate scientific discoveries into clinical applications, helping to develop safer and more effective treatment options for patients. Their expertise is also valuable in optimizing the implementation of new biotechnologies in clinical settings, ensuring that they are accessible and effective for diverse patient populations. They are continually improving the tools and techniques used to treat complex diseases, ultimately enhancing patient outcomes and quality of life. By continually pushing the boundaries of science and medicine, clinical biotechnologists are helping to shape the future of healthcare.
Title : Improving health in over 40,000 patients: The impact of nanomedicine fighting antibiotic resistant infections
Thomas J Webster, Brown University, United States
Title : Advancement in dual lateral flow immunoassay design for sensitive, rapid detection of rotavirus and adenovirus in stool samples
Ayan Ahmed Isse, Genexus Biotech Company, Somalia
Title :
Luis Jesus Villarreal Gomez, Universidad Autonoma de Baja California, Mexico
Title : Renewed novel biotech ideas, with bioreactor bioengineering economic impact
Murray Moo Young, University of Waterloo, Canada
Title : Osmotic lysis–driven Extracellular Vesicle (EV) engineering
Limongi Tania, University of Turin, Italy
Title : Diversity analyses of microbial communities in Armanis gold-polymetallic mine and acid mine drainage: Bioremediation
Anna Khachatryan, SPC Armbiotechnology of NAS of Armenia, Armenia